id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-P-0779-0005,FDA,FDA-2012-P-0779,"FDA/CDER to Valeant Pharmaceuticals Intl., Inc. - Petition Denial Correction",Other,Correction(s),2012-12-26T05:00:00Z,2012,12,2012-12-26T05:00:00Z,,2012-12-26T18:20:49Z,,0,0,090000648119ab94
FDA-2012-P-0779-0004,FDA,FDA-2012-P-0779,"FDA/CDER to Valeant Pharmaceuticals Intl., Inc. - Petition Denial",Other,Denial,2012-12-14T05:00:00Z,2012,12,2012-12-14T05:00:00Z,,2012-12-14T21:27:33Z,,0,0,090000648118ceef
FDA-2012-P-0779-0002,FDA,FDA-2012-P-0779,"Acknowledgement Letter to Valeant Pharmaceuticals International, Inc.",Other,Acknowledgement Letter/Receipt,2012-08-27T04:00:00Z,2012,8,2012-08-27T04:00:00Z,,2012-08-27T19:39:27Z,,0,0,09000064810af0c3
FDA-2012-P-0779-0001,FDA,FDA-2012-P-0779,"Valeant Pharmaceuticals International, Inc. - Citizen Petition",Other,Citizen Petition,2012-08-27T04:00:00Z,2012,8,2012-08-27T04:00:00Z,,2012-12-14T17:56:26Z,,0,0,09000064810a6ec4